Neuroendocrine Tumor Grade 3
3 clinical trials · Condition
◉ Watch Neuroendocrine Tumor Grade 3
| Record | Firm | Date |
|---|---|---|
| Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm (NCT05113355) | Peking Union Medical College Hospital | 2021-11-17 |
Track Neuroendocrine Tumor Grade 3 automatically
Every clearance here is in the API, with alerts when new ones post.